Value through Innovation27 July 2016

Privacy Notice

This Privacy Notice describes how Boehringer Ingelheim International GmbH (hereafter “Boehringer Ingelheim”, “we”, “our”, “us”) uses, stores and discloses (together “process”) the personal data we collect about you through this website. In any event, we will only process your personal data in accordance with applicable data protection and privacy laws (i.e. the General Data Protection Regulation - GDPR).

1. Use of Data and Legal Basis

1.1 Contact form or other requests

We process your data in order to provide you with the agreed or requested services on this website:
• if you request clinical study reports or related clinical documents
• if you send us inquiries about products or possible adverse events.

The legal basis is Article 6 (1) b) GDPR. If you send information about possible adverse events the legal basis is Article 6 (1) c) GDPR (see section 3 for specific information about adverse events).

1.2 Log data

When using the website, certain data, including data sent by the browser (e.g. IP address, kind of Cookies, previous website, time and date, displayed contents) is temporarily stored. We use this data to enable you to use our website and, if necessary, to review and assert our and third-party rights in the event of damage or violations of legal regulations, our terms of use and the rights of third-parties. The legal basis is Article 6 (1) f) GDPR. The log files will be stored for as long as necessary for the respective purpose, in principle no longer than 14days.

1.3 Cookies

We use essential Cookies (small text files placed on your device) on our website. Essential Cookies are necessary for the website to function properly. Such Cookies make a website usable by providing basic functions such as page navigation and access to secure areas of the website or language settings. Due to their importance for the website's functioning, you cannot opt-out from this kind of Cookies. We base the related processing of personal data on Art. 6 (1) b) GDPR

Essential Cookies we use to provide this website include Cookies, which
• detect whether a user has JavaScript enabled,
• allow a visitor to receive site content from one out of multiple servers as the user browses the site,
• maintain the status of the user for all page requests.

The lifetime of essential Cookies we use extends from the respective session up to one year.

1.4 Further purposes for which we process your personal data

We process your personal data to:
• provide you with the contents on our website and answer your requests and inquiries. The legal basis for the processing of this data is Art. 6 (1) b) and f) of the GDPR.
• meet our legitimate interests, including to:
  (i) complete a corporate transaction (e.g., corporate restructuring, sale or assignment of assets, merger); and
  (ii) protect our rights or property, enforce our terms of use and legal notices, and for the establishment, exercise and defence of legal claims.
• meet our legal obligations, any court order or other binding decision.

2. Data Transfer

We may share personal information with third-parties.

2.1 Reporting obligations to regulatory authorities and enforcement of rights

We may share personal data in pharmacovigilance cases as specified in Section 3.

In order to protect our rights or the rights of third-parties, we may also disclose data to rights holders, consultants and authorities in accordance with legal provisions.

2.2 Service provider

We engage service providers to process your personal data for the purposes described in this data protection information. These service providers process the data only on our behalf, in accordance with our instructions and under our control in accordance with this data privacy declaration.

2.3 Boehringer Ingelheim companies

As part of a global group of companies, we involve other Boehringer Ingelheim companies that support us in data processing. These group companies process the data exclusively for the purposes stated in this Privacy Notice.

2.4 Data transfer to recipients outside the EU

Some of these service providers and Boehringer companies process personal data outside the EU. In these cases, we ensure an adequate level of data protection to comply with European law (usually through EU standard contractual clauses published by the European Commission).

3. Specific Privacy Notice for Pharmacovigilance

If you report adverse events or other pharmacovigilance relevant information to a Boehringer Ingelheim product we will use and share this data solely for pharmacovigilance purposes. (Pharmacovigilance is the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.)

All reports will be shared with Boehringer Ingelheim International GmbH who is operating the global pharmacovigilance database.

Boehringer Ingelheim is obliged to report pharmacovigilance relevant information to health authorities worldwide (including to countries that may have another level of data protection compared to the EU). Legal basis: Art. 6 (1) c), and for transfers outside EU Art. 6 (1) f) and Art. 49 (1) e) GDPR.

The reports will contain details about the incident but only limited personal data:
– For patients, the report will only contain, age, gender and initials as provided, but never the patient's name.
– For the reporting individuals, the report will include the name, profession (e.g. physician, pharmacist), initials or address, e-mail and phone number as provided. The contact information is required to be able to follow-up with the reporter to gain high quality and complete information on adverse events. If the reporter does not wish to provide his contact details to Boehringer Ingelheim or authorities, “Privacy” can be entered in reporter's name and contact detail fields.

Where your data is shared with other Boehringer Ingelheim companies, business partners or service providers outside of the EU, we will provide an adequate protection of personal data.

As reports about adverse events are important for public health reasons, reports are kept for minimum of 10 years after withdrawal of the product in the last country where the product is marketed.

4. Deletion

Boehringer Ingelheim processes your personal data for as long as necessary for the purpose of the processing, which mainly is the provision of our services requested by you. In general, we will delete data related to your (customer) requests after 90 days

5. Your Rights

Subject to limitations in applicable law, you have a right of access, rectification, restriction, erasure, and portability of your personal data, as well as the right not to be subject to automated individual decision-making.

You also have the right to withdraw your consent at any time.

Right to object: To the extent we base the processing on Art. 6 (1) f GDPR, you may opt-out from such processing at any time. In this case, we will not process such personal data any longer unless our interests prevail. You can object to the use of data for direct marketing purposes at any time. You may also object to the processing of your personal data for the transfer to authorities outside the EU described above in Section 3 for pharmacovigilance cases unless the interests of Boehringer Ingelheim prevail.

Please send your request or any question you have in relation to our processing of your personal data to:

Boehringer Ingelheim International GmbH
– Data Protection Officer –
Binger Strasse 173
D-55216 Ingelheim am Rhein
Germany
E-Mail: datenschutz@boehringer-ingelheim.com

If you still have concerns, you may have a right to lodge a complaint to the supervisory authority for privacy in your country or responsible for BI:
Der Landesbeauftragte für den Datenschutz und die Informationsfreiheit Rheinland-Pfalz, Hintere Bleiche 34, 55116 Mainz, poststelle@datenschutz.rlp.de